Problems with the “omics”
- 16 November 2006
- journal article
- Published by Elsevier in TrAC Trends in Analytical Chemistry
- Vol. 25 (11), 1046-1056
- https://doi.org/10.1016/j.trac.2006.10.007
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Bias as a threat to the validity of cancer molecular-marker researchNature Reviews Cancer, 2005
- The Need for Guidelines in Publication of Peptide and Protein Identification DataMolecular & Cellular Proteomics, 2004
- A test before its time? FDA stalls distribution process of proteomic test.JNCI Journal of the National Cancer Institute, 2004
- Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophreniaPsychiatric Genetics, 2004
- Detection of cancer-specific markers amid massive mass spectral dataProceedings of the National Academy of Sciences, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003
- Use of proteomic patterns in serum to identify ovarian cancerThe Lancet, 2002
- Minimum information about a microarray experiment (MIAME)—toward standards for microarray dataNature Genetics, 2001
- Replication validity of genetic association studiesNature Genetics, 2001
- Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.Journal of Medical Genetics, 1992